PRAME Gene Expression in Childhood Acute Lymphoblastic Leukemia: Impact on Prognosis

Abstract

Our results suggested that PRAME was a predictor for better outcome, could be a useful target for immunotherapy, and might represent a candidate marker for the monitoring of minimal residual disease.